May 3 |
Vir Biotechnology Inc (VIR) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
|
May 3 |
Vir Biotechnology, Inc. (VIR) Q1 2024 Earnings Call Transcript
|
May 2 |
Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates
|
May 2 |
Vir Biotechnology GAAP EPS of -$0.48 beats by $0.59, revenue of $56.38M beats by $44.67M
|
May 2 |
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
|
May 1 |
Vir Biotechnology Q1 2024 Earnings Preview
|
Apr 30 |
Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024
|
Apr 28 |
With 53% ownership, Vir Biotechnology, Inc. (NASDAQ:VIR) boasts of strong institutional backing
|
Apr 24 |
What Makes Vir Biotechnology (VIR) a New Buy Stock
|
Apr 18 |
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors
|